Viz.ai, a leader in AI-powered disease detection and intelligent care coordination, today announced the launch of the Viz Oncology™ Suite — a transformative AI platform designed to accelerate access to life-saving cancer care. This marks a strategic extension of Viz.ai’s success beyond stroke, cardiology, respiratory, and radiology into oncology.
Addressing Complexity in Cancer Care
Cancer care involves managing vast longitudinal data, cross-specialty collaboration, and urgent, guideline-based interventions. Despite the complexity, oncology workflows remain fragmented and manual, leading to delays and care variability, especially outside major cancer centers. The Viz Oncology Suite delivers an end-to-end AI-driven solution to streamline coordination, surface high-risk patients earlier, and ensure timely care access.
Leadership Insights
Chris Mansi, MD, CEO and co-founder of Viz.ai, emphasized the company’s commitment:
“With the Viz Oncology Suite, we enable a patient-centered, data-driven, and scalable transformation in cancer care, helping teams identify patients faster and get them to the right specialist sooner.”
Sara Nunnery, MD, MSCI, Director of Breast Cancer Research at Tennessee Oncology, added:
“This technology has the potential to enhance oncology workflow efficiency and improve patient outcomes, especially in community care settings.”
Market Impact and Future Outlook
Oncology is among healthcare’s fastest-growing sectors, expected to nearly double revenue over the next decade. The Viz Oncology Suite equips providers with AI-driven tools to deliver timely, guideline-directed care and efficiently manage an increasing volume of complex cancer cases.
The Viz Oncology Suite extends Viz.ai’s proven AI capabilities into oncology, addressing critical care gaps by automating complex workflows, improving care team coordination, and enabling faster patient engagement. This innovation promises to transform cancer care delivery at scale, improving outcomes and expanding access.
